# Effect of Liraglutide on Weight Loss in Patients Who Have Undergone Revisional Bariatric Surgeries.

> **NCT05285397** · NA · UNKNOWN · sponsor: **General Committee of Teaching Hospitals and Institutes, Egypt** · enrollment: 60 (estimated)

## Conditions studied

- Morbid Obesity

## Interventions

- **DRUG:** Liraglutide Pen Injector [Saxenda]

## Key facts

- **NCT ID:** NCT05285397
- **Lead sponsor:** General Committee of Teaching Hospitals and Institutes, Egypt
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-10
- **Primary completion:** 2022-09
- **Final completion:** 2022-09
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05285397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05285397, "Effect of Liraglutide on Weight Loss in Patients Who Have Undergone Revisional Bariatric Surgeries.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05285397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*